- Home
- MIST vs DAKT Comparison
MIST vs DAKT Comparison
Compare MIST & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- DAKT
- Stock Information
- Founded
- MIST 2003
- DAKT 1968
- Country
- MIST Canada
- DAKT United States
- Employees
- MIST N/A
- DAKT N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- DAKT Office Equipment/Supplies/Services
- Sector
- MIST Health Care
- DAKT Industrials
- Exchange
- MIST Nasdaq
- DAKT Nasdaq
- Market Cap
- MIST 53.9M
- DAKT N/A
- IPO Year
- MIST N/A
- DAKT 1994
- Fundamental
- Price
- MIST $1.12
- DAKT $13.94
- Analyst Decision
- MIST Strong Buy
- DAKT Strong Buy
- Analyst Count
- MIST 2
- DAKT 1
- Target Price
- MIST $9.50
- DAKT $26.00
- AVG Volume (30 Days)
- MIST 1.6M
- DAKT 213.7K
- Earning Date
- MIST 05-20-2025
- DAKT 06-25-2025
- Dividend Yield
- MIST N/A
- DAKT N/A
- EPS Growth
- MIST N/A
- DAKT N/A
- EPS
- MIST N/A
- DAKT 0.04
- Revenue
- MIST N/A
- DAKT $799,806,000.00
- Revenue This Year
- MIST N/A
- DAKT N/A
- Revenue Next Year
- MIST N/A
- DAKT $4.86
- P/E Ratio
- MIST N/A
- DAKT $382.01
- Revenue Growth
- MIST N/A
- DAKT N/A
- 52 Week Low
- MIST $0.63
- DAKT $10.24
- 52 Week High
- MIST $2.75
- DAKT $19.89
- Technical
- Relative Strength Index (RSI)
- MIST 46.48
- DAKT 67.70
- Support Level
- MIST $1.28
- DAKT $12.37
- Resistance Level
- MIST $1.32
- DAKT $12.80
- Average True Range (ATR)
- MIST 0.12
- DAKT 0.37
- MACD
- MIST 0.03
- DAKT 0.20
- Stochastic Oscillator
- MIST 38.80
- DAKT 95.77
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).